Browsing by Author Monreal M
Showing results 1 to 18 of 18
| Preview | Title | Author(s) | Issue Date | Type |
|---|---|---|---|---|
| Clinical Characteristics and Outcomes of Patients with Lung Cancer and Venous Thromboembolism | Ruiz-Artacho P,; Trujillo-Santos J,; López-Jiménez L,; Font C,; Díaz-Pedroche MDC,; Sánchez Muñoz-Torrero JF,; Peris ML,; Skride A,; Maestre A,; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M | 2018 | Article | |
| The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site. | Mahé I; Chidiac J; Bertoletti L; Font C; Trujillo-Santos J; Peris M; Pérez Ductor C; Nieto S; Grandone E; Monreal M; RIETE investigators; Bosevski M ; Zdraveska M | 2016 | Article | |
| Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism. | Moustafa F; Giorgi Pierfranceschi M; Di Micco P; Bucherini E; Lorenzo A; Villalobos A; Nieto JA; Valero B; Sampériz ÁL; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M | 2017 | Article | |
| Clinical Presentation and Outcomes of Patients With Cancer-Associated Isolated Distal Deep Vein Thrombosis. | Galanaud JP; Trujillo-Santos J,; Bikdeli B; Bertoletti L,; Di Micco P; Poénou G,; Falgá C; Zdraveska M; Lima J,; Rivera-Civico F; Muixi JF; Monreal M; RIETE Investigators.; Zdraveska M | 2023 | Article | |
| Development of a Risk Prediction Score for Occult Cancer in Patients With VTE | Jara-Palomares L,; Otero R,; Jimenez D,; Carrier M,; Tzoran I,; Brenner B,; Margeli M,; Praena-Fernandez JM,; Grandone E,; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M | 2016 | Article | |
| Fondaparinux in the initial and long-term treatment of venous thromboembolism | Pesavento R; Amitrano M; Trujillo-Santos J; Di Micco P; Mangiacapra S; López-Jiménez L; Piovella C; Prandoni P; Monreal M; RIETE Investigators.; Bosevski M ; Zdraveska M | 2015 | Article | |
| Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry | Alatri A; Mazzolai L; Font C; Tafur A; Valle R; Marchena PJ; Ballaz A; Tiraferri E; Font L; Monreal M; Riete Investigators; Bosevski M ; Zdraveska M | 2017 | Article | |
| Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism. | Peris M; Jiménez D; Maestre A; Font C; Tafur AJ; Mazzolai L; Xifre B; Skride A; Dentali F; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M | 2016 | Article | |
| Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation. | Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M; Registro Informatizado de Enfermedad TromboEmbólica Investigators; Bosevski M ; Zdraveska M | 2017 | Article | |
| Outcomes Associated With Inferior Vena Cava Filters Among Patients With Thromboembolic Recurrence During Anticoagulant Therapy. | Mellado M; Pijoan JI; Jiménez D; Muriel A; Aujesky D; Bertoletti L; Decousus H; Barrios D; Clará A; Yusen RD; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M | 2016 | Article | |
| Predictors of active cancer thromboembolic outcomes. RIETE experience of the Khorana score in cancer-associated thrombosis. | Tafur AJ,; Caprini JA,; Cote L; Trujillo-Santos J; Del Toro J,; Garcia-Bragado F; Tolosa C,; Barillari G,; Visona A,; Monreal M; RIETE Investigators; Bosevski, M ; Zdraveska M | 2017 | Article | |
| Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens | Trujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M | 2017 | Article | |
| Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry | Barillari G; Londero AP; Brenner B; Nauffal D; Muñoz-Torrero JF; Del Molino F; Moustafa F; Madridano O; Martín-Martos F; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M | 2016 | Article | |
| Systolic blood pressure and mortality in acute symptomatic pulmonary embolism | Quezada A,; Jiménez D,; Bikdeli B,; Moores L,; Porres-Aguilar M,; Aramberri M,; Lima J,; Ballaz A,; Yusen RD, Monreal M; RIETE investigators.; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M | 2020 | Article | |
| Uterine bleeding during anticoagulation in women with venous thromboembolism. | Moustafa F,; Fernández S,; Fernández-Capitán C,; Nieto JA,; Pedrajas JM,; Visoná A,; Valero B,; Marchena PJ,; Braester A,; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M | 2017 | Article | |
| Venous thromboembolism in centenarians: Findings from the RIETE registry | Lacruz B; Tiberio G; Núñez MJ; López-Jiménez L; Riera-Mestre A; Tiraferri E; Verhamme P; Mazzolai L; González J; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M | 2016 | Article | |
| Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry | Portillo J; de la Rocha VI; Font L; Braester A; Madridano O; Peromingo JA; Apollonio A; Pagán B; Bascuñana J; Monreal M; RIETE Investigations; Bosevski M ; Zdraveska M | 2015 | Article | |
| Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism | Chai-Adisaksopha C; Iorio A; Crowther MA; de Miguel J; Salgado E; Marija Zdraveska ; Fernández-Capitán C; Nieto JA; Barillari G; Bertoletti L; Monreal M; RIETE investigators | Apr-2018 | Article |